ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia.

Keith W Pratz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.